Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital, Inc. (HTGC) – Form 4 filing: Chief Legal Officer & Chief Compliance Officer Kiersten Zaza Botelho reported an automatic share withholding on 9 July 2025 related to the vesting of restricted stock. The company withheld 912 common shares at a price of $18.56 per share to cover applicable taxes (Transaction Code F). Following the transaction, the executive retains 66,651 directly held shares. Because the shares were not sold on the open market and merely satisfied tax obligations, the event neither increases nor decreases the executive’s economic exposure to HTGC and is typically viewed as administrative rather than directional trading activity.
Hercules Capital, Inc. (HTGC) – Form 4 filing reports an internal share withholding transaction by Chief Executive Officer Scott Bluestein on 07/09/2025. The transaction was coded “F”, indicating that 10,593 common shares were withheld by the company to cover taxes triggered by the vesting of previously granted restricted stock. No open-market purchase or sale occurred. Following the withholding, Bluestein’s direct beneficial ownership stands at 2,281,611 common shares. No derivative securities were involved, and the filing does not alter the executive’s status or the company’s capital structure. For investors, the event is procedural and does not reflect a change in the CEO’s net economic exposure to HTGC.